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Abstract
This commentary highlights some of the valuable insights gained from a special collection of 
papers that utilized data from the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) and appear in this special issue. The data and experiences of the NBCCEDP can 
inform the identification of new opportunities and directions for meeting the cancer screening 
needs of underserved women in a complex and changing health care environment.
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For more than two decades, the National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) has provided access to breast and cervical cancer screening and 
diagnostic services to more than 4 million low-income, underinsured, and uninsured women 
in the USA [1]. The NBCCEDP is implemented by the Centers for Disease Control and 
Prevention (CDC) through cooperative agreements awarded to health departments in all 50 
states and the District of Columbia as well as selected tribes, tribal organizations, and US 
territories. The NBCCEDP is the largest organized cancer screening program in the nation 
and, by design, reaches women who are underserved and not well represented in other 
healthcare systems. Of the funds provided to grantees under the NBCCEDP, a small 
proportion is used to process data submitted by providers on demographic characteristics 
and clinical outcomes for the women they serve [2]. Known as the Minimum Data Elements 
(MDEs), these standardized data (without personal identifiers) are used by CDC to monitor 
and evaluate program performance [3-5]. Although not designed for research, the data 
collected through the NBCCEDP can be used to examine some of the practical challenges to 
ensuring that low-income women in the USA benefit from the promise of early detection of 
© Springer International Publishing Switzerland (outside the USA) 2015
mxw5@cdc.gov. 
The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers 
for Disease Control and Prevention.
HHS Public Access
Author manuscript
Cancer Causes Control. Author manuscript; available in PMC 2016 May 01.
Published in final edited form as:
Cancer Causes Control. 2015 May ; 26(5): 805–809. doi:10.1007/s10552-015-0541-4.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
breast and cervical cancer. The findings from such analyses can inform future efforts to 
improve the provision of preventive health services for low-income women and the impact 
of such services on death rates for breast and cervical cancer. This commentary highlights 
some of the valuable insights gained from a collection of papers that utilized data from the 
NBCCEDP and appear in this special issue.
Serving priority populations
Given the level of resources available to NBCCEDP grantees relative to the unmet needs for 
screening services, effective utilization of program resources is essential. A key component 
to effective public health program implementation is managing performance, and this 
requires accurate and timely information systems [6]. In 2006, the NBCCEDP implemented 
a performance management system including 11 priority indicators based on the MDEs [7]. 
Two of the indicators emphasize priority populations: At least 20 % of newly enrolled 
women receiving cervical cancer screening must be rarely or never before screened and at 
least 75 % of the women receiving mammograms must be 50 years of age or older. Analyses 
of recent data on clinical outcomes demonstrate that cancer detection rates were higher for 
these priority populations compared to other women who were screened through the 
NBCCEDP. Benard et al. [8] report that among women 40 years and older, those who had 
rarely or never been screened for cervical cancer had higher percentages of abnormal Pap 
tests and invasive disease compared to women who reported having a Pap test within the last 
5 years. In addition, regardless of whether the mammogram was conducted for screening or 
diagnosis, White et al. [9] found that breast cancer detection was higher among women 50 
years and older compared to younger women. These findings lend support to the 
NBCCEDP’s focus on priority populations where disease is more evident.
The limits to what increased program efficiency can achieve
The articles by Tangka et al. [10] and Howard et al. [11] show that although the NBCCEDP 
has national scope, women receiving services represent only a small fraction of the women 
who met NBCCEDP eligibility criteria based on age, income, and health insurance status. 
For cervical cancer screening, 6.5 % of eligible women 18–64 years old received Pap tests 
through the NBCCEDP [10]. This proportion is higher for women 40–64 years old, but still 
fairly small at 16.5 % [10]. An estimated one-third of all eligible women were not screened 
for cervical cancer, either within or outside the NBCCEDP. For mammography, 10.6 % of 
eligible women 40–64 years old received a mammogram through the NBCCEDP within a 2-
year period [11]. An estimated 30 % of eligible women received a mammogram outside of 
the NBCCEDP, and about 60 % of all eligible women were not screened for breast cancer 
[11].
Some state grantees provided Pap tests and mammograms to a larger proportion of eligible 
women than other states [10, 11]. Subramanian et al. [12] examined the factors associated 
with this variability and identified several program and state-level characteristics as 
important. A larger number of eligible women, a higher average cost of screening (which 
includes the cost of screening and diagnostic evaluation and cost of program operations), 
and a greater proportion of women in urban areas all were associated with a lower 
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proportion of eligible women being screened. An earlier analysis of program data revealed 
strong evidence that the average cost of providing screening services declines with larger 
numbers of women screened [13]. Thus, in addition to limited funds, some of the factors that 
are restraining the ability of grantees to serve more women are structural and not easily 
modified by NBCCEDP grantees.
A window into the experiences of vulnerable women and their providers
Some of the women who received services through the NBCCEDP had symptoms or had 
been referred to the NBCCEDP because of an abnormal screening test performed elsewhere. 
For both breast and cervical cancer, the articles by White et al. [9] and Benard et al. [8] 
show that these referrals were more common among younger women. Ryerson et al. [14] 
reported that the most common breast symptoms were pain or tenderness and breast lump. 
Although low, the proportion of women with symptoms who received a diagnosis of 
invasive breast cancer was substantially elevated compared to asymptomatic women, 
especially if they reported a breast lump or inflammation or changes to the skin or nipple. 
Most women who received mammograms through the NBCCEDP reported no symptoms. 
Wu et al. [15] analyzed cancer registry data for women enrolled in the NBCCEDP. 
Compared to other women with breast cancer, women whose breast cancer had been 
diagnosed through the NBCCEDP had a poorer stage distribution of breast cancer. Miller et 
al. [16] further examined stage of diagnosis for women served by the NBCCEDP. Distant 
stage breast cancers were more common among older women, black women, and those 
whose mammograms were regarded as diagnostic; distant stage cervical cancer was more 
common among older women and those who had not been screened within the last 5 years. 
These findings indicate that the NBCCEDP continues to reach women who are medically 
underserved.
The network of primary care physicians who serve women through the NBCCEDP is 
established locally by the grantee. These providers are willing to serve low-income women 
at the Medicare reimbursement rate as required by the NBCCEDP’s authorizing legislation 
(The Breast and Cervical Cancer Mortality Prevention Act of 1990); typically, these 
providers also see low-income women in their communities who are not NBCCEDP 
participants. Based on the results from a national sample of primary care providers from 
2006 to 2007, providers who participated in the NBCCEDP were found to report beliefs and 
screening practices similar to those of providers who were not NBCCEDP participants [17]. 
Watson et al. [18] analyzed recent MDE data to examine the quality of follow-up when the 
Pap test results were equivocal. Most of these women were followed with the HPV test and 
received recommended management if they were found to be HPV positive. Thus, 
NBCCEDP providers appeared to be changing their practices to be consistent with changing 
screening guidelines.
Innovative approaches to building the evidence base
Innovation is another essential component to effective program implementation [6], and the 
NBCCEDP has fostered innovative approaches to recruit and serve often hardto-reach 
populations. Programs are encouraged to use interventions that have been formally 
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evaluated and demonstrated to be effective at increasing screening for breast and cervical 
cancer [19]. To date, limited evidence exists for all but a few proven strategies, such as one-
onone education and client reminders. For example, special events such as health fairs are 
fairly common, but the evidence is insufficient to demonstrate their effectiveness at 
increasing cancer screening [20].
In addition to research studies, the rigorous evaluation of strong programs can contribute to 
the evidence base in support of specific intervention strategies. DeGroff et al. [21] described 
an effort to identify promising practices within the NBCCEDP. While few promising 
practices were found, a bundled payment model used by the Colorado program was 
identified and underwent a rigorous evaluation. This study also identified important 
problems in the implementation of non-screening activities related to dose and fidelity. As a 
result, increased attention was given to improving grantee capacity in program planning, 
implementation, and evaluation. Hall et al. [22] reported on a recent pilot study in Georgia 
to increase mammography use among African American women. A multimedia campaign 
that included black radio was shown to increase awareness of the program among eligible 
African American women. Program data were used to evaluate the impact of the 
intervention [22]. The evidence-based AMIGAS educational program to increase cervical 
cancer screening, targeting Hispanic women who have rarely or never had a Pap test, is 
another example of an innovative approach to reaching underserved women [23]. With 
increased attention to logic modeling for program planning and evaluation among 
NBCCEDP grantees, more promising practices can be tested and evaluated.
Cancer screening for underserved women after age 64
About one-third of all cervical cancer deaths and well over half of all breast cancer deaths in 
the USA occur among women aged 65 years and older [24]. The USPSTF recommends 
biennial screening mammography for women aged 50–74 years [25], up to 10 years later 
than the upper age eligibility for the NBCCEDP. Although the USPSTF does not 
recommend routine screening for cervical cancer for average risk women older than age 65 
years with adequate prior testing, screening may be indicated for older women with limited 
access to care, minority women, and other women who are less likely to meet the criteria for 
adequate prior screening [26]. In addition, the recommendation to not screen for cervical 
cancer after age 65 does not apply to women with a prior history of high-grade precancerous 
cervical lesions or cervical cancer, in utero exposure to diethylstilbestrol (DES), or HIV 
infection [26]. Thus, the need for cancer screening services continues after women age out 
of eligibility for the NBCCEDP and become eligible for Medicare.
For low-income women under the age of 65 years, being underinsured may serve as a barrier 
to screening. The Affordable Care Act requires that screening for breast and cervical cancer 
be provided without cost sharing for women enrolled in non-grandfathered private insurance 
plans, including all plans purchased through the Health Insurance Marketplace and 
beneficiaries newly eligible for Medicaid through the expansion. However, for these 
women, cost sharing is not eliminated for recommended diagnostic follow-up tests resulting 
from abnormal screening tests. Even after women become eligible for Medicare, many may 
remain medically underserved because of similar limitations in coverage. Although 
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Medicare Part B covers Pap tests and screening mammograms at no cost if the doctor 
accepts Medicare, women may have to pay some or all of the costs associated with 
recommendations for the follow-up of abnormal test results (www. medicare/gov/coverage). 
Some women may remain underinsured because they cannot afford the premiums for 
Medicare Part B or the premiums for supplemental insurance to cover the significant cost 
sharing involved with traditional fee-for-service Medicare. Adams et al. [27] examined 
women who recently had become eligible for Medicare in Georgia. These women were far 
less likely to receive a mammogram within 18 months of enrollment if they had non-
continuous Medicare Part B coverage or only Medicare Part A.
In this same study by Adams et al. [27], women who had participated in the Georgia Breast 
and Cervical Cancer Program were more likely to be rescreened by mammography after 
enrollment in Medicare than non-participants. In addition, a larger percentage of the breast 
cancers detected among previous program participants were diagnosed at in situ or localized 
disease stage compared to all breast cancer cases reported to the Georgia cancer registry. 
These findings suggest that educational and support components of the program may have 
established a practice of regular screening that persists once women age out of program 
eligibility.
Going forward
The NBCCEDP has developed a nationwide organized cancer screening program that 
effectively utilizes limited resources to reach medically underserved women and provide 
access to priority populations. The NBCCEDP is grounded in current evidence-based 
screening and intervention recommendations, innovation, and the continuous monitoring of 
quality to inform program improvements. This has resulted in a strong infrastructure built on 
experience that will be essential in navigating today’s rapidly changing healthcare 
environment to increase cancer screening rates.
Population-based efforts aimed at increasing access to services and reducing disparities are 
projected to be essential for the achievement of Healthy People 2020 objectives for cancer 
screening [28]. Despite the successes of the NBCCEDP, serious challenges remain to 
meeting the cancer screening needs of underserved women. Of all US women aged 40–64 
years who met NBCCEDP eligibility criteria, it was estimated that nearly six out of ten 
women had not received a mammogram within the last 2 years [11], and four out of ten had 
not received a Pap test within the last 3 years [10], even when sources for screening services 
outside the NBCCEDP were considered. These discouraging findings point to the need for 
more targeted outreach and population-based activities to reach a greater number of 
underserved women, regardless of the payer. Expanded efforts also are needed to make 
screening services available and affordable to a larger number of underserved women.
Implementation of the Affordable Care Act provides new access to cancer screening for 
millions of people who were previously uninsured. It also offers new opportunities for the 
NBCCEDP to expand its role with health systems partners such as Federally Qualified 
Health Centers (FQHCs) or health plans; payers such as Medicaid or Medicare; and 
purchasers such as employers, as well as community partners to increase cancer screening 
White and Wong Page 5
Cancer Causes Control. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
on a population level [29]. Partnerships to systematically improve organized approaches to 
cancer screening through the use of evidence-based interventions and to effectively address 
non-screening barriers such as language and cultural barriers, lack of awareness and 
knowledge about screening, lack of transportation or child care, lack of paid sick leave, or 
similar barriers will help to address the continuing disparities found in cancer screening [29, 
30]. Scientific research can shape these efforts and identify new approaches to meet national 
goals to eliminate health disparities [31]. The use of program data could be expanded 
through linkages with other data sources, such as cancer registries [32].
This unique collection of timely papers based on the data and experiences of the NBCCEDP 
enhances our understanding of the challenges and opportunities for meeting the cancer 
screening needs of underserved women. Together, the papers in this special issue provide a 
baseline against which future progress toward meeting these needs can be assessed.
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